Insider trade

Moderna (MRNA): President sold ~$7.18M

Stephen Hoge, President at Moderna, sold ~$7.18M of Moderna shares.

~$7.18M
Approx. value · 34K sh @ $211.45
1.32M
Holds after · shares reported
Traded
Nov 17, 2026
Filed
Nov 18, 2026

What stands out in this filing

  • The sale was 2.5% of the shares this insider held before it; the filing reports 1,316,334 shares afterwards.
  • 33,976 shares at an average of $211.45 each, as reported on the form.
  • Footnote references a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 24, 2026CongressDisclosed partial sale of MRNA — reported range $1,001 - $15,000
  2. Sep 30, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 30, 2026, Moderna, Inc. (“Moderna” or the “Company”) announced the appointment of Juan Andres as its Chief Operating Officer (“COO”) effective October 5, 2026.”
  3. Oct 14, 2026Insider · 1 personInsiders: 2 sales (~$8.4M)
  4. Oct 15, 2026InsiderOfficer sold ~$8.64M of MRNA shares in the open market
  5. Oct 20, 2026CongressDisclosed purchase of MRNA — reported range $1,001 - $15,000
  6. Nov 5, 20265% stakeFMR LLC reported a passive stake (13G) of 14.8%
  7. Nov 6, 2026Company filing · Form 8-K · ResultsReported its results
  8. Nov 13, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 13, 2026 , Moderna, Inc. (the “Company”) entered into a Transitional Services and Retirement Agreement (the “Retirement Agreement”) with Shannon Thyme Klinger, the Company’s Chief Legal Officer, that sets forth the terms of Ms. Klinger’s retirement from the Company.”
  9. Nov 16, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  10. Nov 16, 2026InsiderOfficer sold ~$8.6M of MRNA shares in the open market
  11. Nov 17, 2026 · this disclosureInsiderOfficer sold ~$7.18M of MRNA shares in the open market

What came next

  1. Nov 17, 2026Insider · 1 personInsiders: 2 sales (~$1.1M)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Moderna

For Moderna, OQRO holds 19 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MRNA page.

Other recent filings by Stephen Hoge, President

The full history of Stephen Hoge, President is on the profile page.

How this filing works

Explore the data

Common questions

Which Moderna (MRNA) insider traded, and how much?

Stephen Hoge, President at Moderna, sold ~$7.18M of Moderna shares. 34K shares at $211.45.

When did it happen, and when was it made public?

Traded: Nov 17, 2026. Filed: Nov 18, 2026. That is 1 day between the two dates.

What stands out in this filing?

The sale was 2.5% of the shares this insider held before it; the filing reports 1,316,334 shares afterwards. 33,976 shares at an average of $211.45 each, as reported on the form. Footnote references a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Moderna recently?

For Moderna, OQRO holds 19 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the MRNA page.

Does this mean MRNA stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Moderna

Everything OQRO holds on this company is on its MRNA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data